Q2 2023 · 13F-HR
TANG CAPITAL MANAGEMENT LLCholdings as filed
Filed 2023-08-14 · accession 0001214659-23-011255
$679.3M
Reported value
99
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 032724106 | ANAB | ANAPTYSBIO INC | $39.7M | 5.84% | 1,950,609 | Common | SHARED |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $32.1M | 4.73% | 1,779,158 | Common | SHARED |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $29.4M | 4.33% | 1,137,107 | Common | SHARED |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $24.5M | 3.61% | 1,300,000 | Common | SHARED |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $24.3M | 3.58% | 405,600 | Common | SHARED |
| 09609G100 | — | BLUEBIRD BIO INC | $24.3M | 3.58% | 7,382,827 | Common | SHARED |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $23.9M | 3.51% | 2,651,393 | Common | SHARED |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $23.0M | 3.39% | 320,000 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $22.5M | 3.32% | 3,097,399 | Common | SHARED |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $19.0M | 2.80% | 300,000 | Common | SHARED |
| 649445103 | NYCBEUR | NEW YORK CMNTY BANCORP INC | $18.1M | 2.66% | 1,606,600 | Common | SHARED |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $17.2M | 2.54% | 2,450,000 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $16.5M | 2.43% | 692,925 | Common | SHARED |
| 07725L102 | ONC | BEIGENE LTD | $15.2M | 2.23% | 85,000 | Common | SHARED |
| 92243G108 | PCVX | VAXCYTE INC | $15.0M | 2.21% | 300,000 | Common | SHARED |
| 532457108 | LLY | LILLY ELI & CO | $14.1M | 2.07% | 30,000 | Common | SHARED |
| N44821101 | IFRX | INFLARX NV | $12.9M | 1.90% | 2,900,000 | Common | SHARED |
| 046353108 | AZNN | ASTRAZENECA PLC | $12.2M | 1.79% | 170,000 | Common | SHARED |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $11.4M | 1.67% | 6,600,000 | Common | SHARED |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $11.3M | 1.67% | 3,026,455 | Common | SHARED |
| 09077B104 | BCABGBP | BIOATLA INC | $11.0M | 1.62% | 3,674,076 | Common | SHARED |
| 02155H200 | ALT | ALTIMMUNE INC | $9.7M | 1.43% | 2,750,000 | Common | SHARED |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $9.5M | 1.40% | 271,200 | Common | SHARED |
| 98985Y108 | ZYME | ZYMEWORKS DEL INC | $9.5M | 1.40% | 1,100,000 | Common | SHARED |
| 60770K107 | MRNA | MODERNA INC | $9.3M | 1.37% | 76,700 | Common | SHARED |
| 14040H105 | COF | CAPITAL ONE FINL CORP | $8.7M | 1.29% | 80,000 | Common | SHARED |
| 88427A107 | — | THIRD HARMONIC BIO INC | $8.7M | 1.27% | 1,800,000 | Common | SHARED |
| 92337C203 | VSTM | VERASTEM INC | $8.5M | 1.25% | 1,140,000 | Common | SHARED |
| 023111206 | — | AMARIN CORP PLC | $8.4M | 1.24% | 7,100,000 | Common | SHARED |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $8.4M | 1.24% | 600,000 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $8.2M | 1.21% | 200,000 | Common | SHARED |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $6.1M | 0.90% | 4,000,000 | Common | SHARED |
| 090572207 | BIO | BIO RAD LABS INC | $6.1M | 0.89% | 16,000 | Common | SHARED |
| 007002108 | TORCEUR | ADICET BIO INC | $6.0M | 0.89% | 2,479,552 | Common | SHARED |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $5.4M | 0.80% | 3,613,280 | Common | SHARED |
| 38870X104 | GRPH | GRAPHITE BIO INC | $5.4M | 0.80% | 2,085,625 | Common | SHARED |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $4.8M | 0.71% | 450,000 | Common | SHARED |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $4.6M | 0.68% | 1,260,000 | Common | SHARED |
| 172967424 | C | CITIGROUP INC | $4.6M | 0.68% | 100,000 | Common | SHARED |
| 55910K108 | — | MAGENTA THERAPEUTICS INC | $4.6M | 0.68% | 6,060,000 | Common | SHARED |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $4.6M | 0.67% | 1,787,775 | Common | SHARED |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $4.5M | 0.67% | 4,887,238 | Common | SHARED |
| 75082Q105 | — | RAIN ONCOLOGY INC | $4.5M | 0.66% | 3,740,341 | Common | SHARED |
| 372279109 | GNFTY | GENFIT S A | $4.4M | 0.64% | 1,234,436 | Common | SHARED |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $4.3M | 0.63% | 3,333,803 | Common | SHARED |
| 294100102 | ENZB | ENZO BIOCHEM INC | $4.2M | 0.62% | 2,300,000 | Common | SHARED |
| G6674U108 | NVCR | NOVOCURE LTD | $4.2M | 0.61% | 100,000 | Common | SHARED |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $4.1M | 0.61% | 1,128,068 | Common | SHARED |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $3.9M | 0.57% | 300,000 | Common | SHARED |
| 923451108 | VBTX | VERITEX HLDGS INC | $3.8M | 0.55% | 210,000 | Common | SHARED |
| 36315X101 | LKFT | GALAPAGOS NV | $3.6M | 0.54% | 89,650 | Common | SHARED |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $3.6M | 0.53% | 250,000 | Common | SHARED |
| 69945Q105 | — | PARDES BIOSCIENCES INC | $3.5M | 0.52% | 1,945,206 | Common | SHARED |
| 457669307 | INSM | INSMED INC | $3.5M | 0.52% | 166,203 | Common | SHARED |
| G1110E107 | BHVN | BIOHAVEN LTD | $3.3M | 0.49% | 140,000 | Common | SHARED |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $3.3M | 0.49% | 700,000 | Common | SHARED |
| 902973304 | USB | US BANCORP DEL | $3.3M | 0.49% | 100,000 | Common | SHARED |
| 01626L105 | — | ALIGOS THERAPEUTICS INC | $3.2M | 0.48% | 3,329,048 | Common | SHARED |
| 65487U108 | NKTX | NKARTA INC | $3.0M | 0.45% | 1,385,829 | Common | SHARED |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $2.9M | 0.43% | 80,000 | Common | SHARED |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $2.7M | 0.40% | 409,463 | Common | SHARED |
| 126600105 | CVBF | CVB FINL CORP | $2.7M | 0.39% | 200,000 | Common | SHARED |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $2.6M | 0.38% | 1,850,000 | Common | SHARED |
| 05455M100 | — | AVROBIO INC | $2.6M | 0.38% | 2,705,000 | Common | SHARED |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $2.5M | 0.37% | 250,000 | Common | SHARED |
| 55279B301 | LITS | MEI PHARMA INC | $2.4M | 0.35% | 361,084 | Common | SHARED |
| 269796108 | EGRX | EAGLE PHARMACEUTICALS INC | $2.3M | 0.34% | 118,857 | Common | SHARED |
| 53000N108 | LIANY | LIANBIO | $2.2M | 0.32% | 962,022 | Common | SHARED |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $2.2M | 0.32% | 100,000 | Common | SHARED |
| 06652K103 | BKU | BANKUNITED INC | $2.2M | 0.32% | 100,000 | Common | SHARED |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $2.1M | 0.32% | 1,850,000 | Common | SHARED |
| 294628102 | HP5A | EQUITY COMWLTH | $2.0M | 0.30% | 100,000 | Common | SHARED |
| 04335A105 | ARVN | ARVINAS INC | $2.0M | 0.29% | 80,000 | Common | SHARED |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $1.7M | 0.25% | 400,000 | Common | SHARED |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $1.6M | 0.24% | 200,000 | Common | SHARED |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $1.5M | 0.21% | 150,000 | Common | SHARED |
| 062540109 | BOH | BANK HAWAII CORP | $1.2M | 0.18% | 30,000 | Common | SHARED |
| 81768T108 | SFBS | SERVISFIRST BANCSHARES INC | $1.2M | 0.18% | 30,000 | Common | SHARED |
| 00534A102 | IVVD | INVIVYD INC | $1.2M | 0.18% | 1,151,843 | Common | SHARED |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $1.1M | 0.17% | 20,000 | Common | SHARED |
| 04746L104 | — | ATHIRA PHARMA INC | $1.0M | 0.15% | 352,715 | Common | SHARED |
| 45791E107 | — | INSPIRATO INCORPORATED | $1.0M | 0.15% | 1,035,000 | Common | SHARED |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $892,500 | 0.13% | 10,000 | Common | SHARED |
| 65343E108 | NXTCEUR | NEXTCURE INC | $720,000 | 0.11% | 400,000 | Common | SHARED |
| 65443P102 | MASS | 908 DEVICES INC | $686,000 | 0.10% | 100,000 | Common | SHARED |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $664,000 | 0.10% | 200,000 | Common | SHARED |
| 70465T107 | PDSB | PDS BIOTECHNOLOGY CORP | $503,000 | 0.07% | 100,000 | Common | SHARED |
| 858927106 | STEL | STELLAR BANCORP INC | $457,800 | 0.07% | 20,000 | Common | SHARED |
| 816212104 | SELBUSD | SELECTA BIOSCIENCES INC | $448,000 | 0.07% | 400,000 | Common | SHARED |
| 64131A105 | STIM | NEURONETICS INC | $430,000 | 0.06% | 200,000 | Common | SHARED |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $379,273 | 0.06% | 63,636 | Common | SHARED |
| 002120202 | ATYR | ATYR PHARMA INC | $324,000 | 0.05% | 150,000 | Common | SHARED |
| 29446K106 | EQ | EQUILLIUM INC | $300,000 | 0.04% | 400,000 | Common | SHARED |
| 702712100 | — | PASSAGE BIO INC | $282,390 | 0.04% | 300,000 | Common | SHARED |
| 35655L206 | — | FREELINE THERAPEUTICS HLDGS | $258,000 | 0.04% | 100,000 | Common | SHARED |
| 60853G106 | MOLN | MOLECULAR PARTNERS AG | $247,264 | 0.04% | 39,753 | Common | SHARED |
| 00444T209 | TLPH | ACELRX PHARMACEUTICALS INC | $216,450 | 0.03% | 195,000 | Common | SHARED |
| 168913309 | CREGEUR | SMART POWERR CORP | $202,599 | 0.03% | 125,061 | Common | SHARED |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $80,298 | 0.01% | 139,600 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.